437 related articles for article (PubMed ID: 16406081)
1. Oral lesions in Brazilian HIV-infected children undergoing HAART.
Miziara ID; Filho BC; Weber R
Int J Pediatr Otorhinolaryngol; 2006 Jun; 70(6):1089-96. PubMed ID: 16406081
[TBL] [Abstract][Full Text] [Related]
2. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
Ortega KL; Vale DA; Magalhães MH
J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
[TBL] [Abstract][Full Text] [Related]
3. Otitis media in Brazilian human immunodeficiency virus infected children undergoing antiretroviral therapy.
Miziara ID; Weber R; Araújo Filho BC; Pinheiro Neto CD
J Laryngol Otol; 2007 Nov; 121(11):1048-54. PubMed ID: 17319998
[TBL] [Abstract][Full Text] [Related]
4. Oral candidosis and oral hairy leukoplakia as predictors of HAART failure in Brazilian HIV-infected patients.
Miziara ID; Weber R
Oral Dis; 2006 Jul; 12(4):402-7. PubMed ID: 16792726
[TBL] [Abstract][Full Text] [Related]
5. Effect of PI-HAART on the prevalence of oral lesions in HIV-1 infected patients. A Greek study.
Nicolatou-Galitis O; Velegraki A; Paikos S; Economopoulou P; Stefaniotis T; Papanikolaou IS; Kordossis T
Oral Dis; 2004 May; 10(3):145-50. PubMed ID: 15089923
[TBL] [Abstract][Full Text] [Related]
6. Oral lesions as predictors of highly active antiretroviral therapy failure in Brazilian HIV-infected children.
Miziara ID; Weber R
J Oral Pathol Med; 2008 Feb; 37(2):99-106. PubMed ID: 18197855
[TBL] [Abstract][Full Text] [Related]
7. Oral Candida colonization and its relation with predisposing factors in HIV-infected children and their uninfected siblings in Brazil: the era of highly active antiretroviral therapy.
Cerqueira DF; Portela MB; Pomarico L; de Araújo Soares RM; de Souza IP; Castro GF
J Oral Pathol Med; 2010 Feb; 39(2):188-94. PubMed ID: 20040023
[TBL] [Abstract][Full Text] [Related]
8. Oro-facial lesions and CD4 counts associated with HIV/AIDS in an adult population in Oyo State, Nigeria.
Adurogbangba MI; Aderinokun GA; Odaibo GN; Olaleye OD; Lawoyin TO
Oral Dis; 2004 Nov; 10(6):319-26. PubMed ID: 15533205
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of HIV associated oral lesions among adults in the era of HAART.
Mthethwa SR; Wanjau J; Chabikuli N
SADJ; 2013 Sep; 68(8):364-71. PubMed ID: 24660404
[TBL] [Abstract][Full Text] [Related]
10. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
[TBL] [Abstract][Full Text] [Related]
11. The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: a UK study.
Tappuni AR; Fleming GJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Dec; 92(6):623-8. PubMed ID: 11740479
[TBL] [Abstract][Full Text] [Related]
12. Oral manifestations related to immunosuppression degree in HIV-positive children.
Santos LC; Castro GF; de Souza IP; Oliveira RH
Braz Dent J; 2001; 12(2):135-8. PubMed ID: 11450684
[TBL] [Abstract][Full Text] [Related]
13. HAART impact on prevalence of chronic otitis media in Brazilian HIV-infected children.
Weber R; Pinheiro Neto CD; Miziara ID; Araújo Filho BC
Braz J Otorhinolaryngol; 2006; 72(4):509-14. PubMed ID: 17143430
[TBL] [Abstract][Full Text] [Related]
14. Opportunistic infections and organ-specific diseases in HIV-1-infected children: a cohort study (1990-2006).
Guillén S; García San Miguel L; Resino S; Bellón JM; González I; Jiménez de Ory S; Muñoz-Fernández MA; Navarro ML; Gurbindo MD; de José MI; Mellado MJ; Martín-Fontelos P; Gonzalez-Tomé MI; Martinez J; Beceiro J; Roa MA; Ramos JT;
HIV Med; 2010 Apr; 11(4):245-52. PubMed ID: 20050937
[TBL] [Abstract][Full Text] [Related]
15. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.
Resino S; Resino R; Micheloud D; Gurbindo Gutiérrez D; Léon JA; Ramos JT; Ciria L; de José I; Mellado J; Muñoz-Fernández A;
Clin Infect Dis; 2006 Mar; 42(6):862-9. PubMed ID: 16477566
[TBL] [Abstract][Full Text] [Related]
17. Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: a new face of oral AIDS?
Ceballos-Salobreña A; Gaitán-Cepeda LA; Ceballos-Garcia L; Lezama-Del Valle D
AIDS Patient Care STDS; 2000 Dec; 14(12):627-35. PubMed ID: 11119429
[TBL] [Abstract][Full Text] [Related]
18. Oral manifestations of HIV infection in patients receiving highly active antiretroviral therapy (HAART) in Bahia, Brazil.
da Silva CA; Dourado I; Dahia SR; Harzheim E; Rutherford GW
J Public Health Dent; 2008; 68(3):178-81. PubMed ID: 18248345
[TBL] [Abstract][Full Text] [Related]
19. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
20. Oral manifestations in HIV/AIDS infected patients from India.
Sharma G; Pai KM; Suhas S; Ramapuram JT; Doshi D; Anup N
Oral Dis; 2006 Nov; 12(6):537-42. PubMed ID: 17054765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]